Stockscreener 앱 받기
10.55
6.57%
0.65
시장 영업 전:
10.70
0.15
+1.42%
전일 마감가:
$9.90
열려 있는:
$9.92
하루 거래량:
11.13M
Relative Volume:
2.20
시가총액:
$3.26B
수익:
$571.16M
순이익/손실:
$-38.10M
주가수익비율:
-86.12
EPS:
-0.1225
순현금흐름:
$-48.91M
1주 성능:
+6.57%
1개월 성능:
+12.00%
6개월 성능:
+70.99%
1년 성능:
+3.94%
1일 변동 폭
$9.78
$11.00
1주일 범위
$9.725
$11.00
52주 변동 폭
$5.51
$11.00
아미쿠스 테라 Stock (FOLD) Company Profile
명칭
Amicus Therapeutics Inc
전화
(609) 662-2000
주소
47 HULFISH STREET, PRINCETON, NJ
FOLD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FOLD
Amicus Therapeutics Inc
|
10.55 | 3.05B | 571.16M | -38.10M | -48.91M | -0.1225 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
아미쿠스 테라 Stock (FOLD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-18 | 업그레이드 | Needham | Hold → Buy |
| 2025-07-17 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-13 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-09-06 | 개시 | Jefferies | Buy |
| 2024-05-30 | 개시 | Wells Fargo | Overweight |
| 2024-05-14 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2023-12-19 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-09-09 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-04-13 | 재개 | Goldman | Neutral |
| 2022-01-14 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2021-11-15 | 업그레이드 | Stifel | Hold → Buy |
| 2021-09-30 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-07-19 | 재개 | BTIG Research | Buy |
| 2021-05-27 | 개시 | Needham | Hold |
| 2021-05-21 | 개시 | UBS | Buy |
| 2021-04-14 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2021-03-02 | 개시 | Stifel | Hold |
| 2021-02-12 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2021-02-12 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-12-28 | 재개 | Cantor Fitzgerald | Overweight |
| 2020-12-10 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-11-11 | 개시 | Berenberg | Hold |
| 2020-06-17 | 개시 | BTIG Research | Buy |
| 2020-02-04 | 재개 | Cantor Fitzgerald | Overweight |
| 2019-11-12 | 재확인 | H.C. Wainwright | Buy |
| 2019-06-17 | 개시 | H.C. Wainwright | Buy |
| 2019-06-05 | 재확인 | Cantor Fitzgerald | Overweight |
| 2019-04-05 | 개시 | Janney | Buy |
| 2019-01-30 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-10-29 | 개시 | Citigroup | Neutral |
| 2018-08-17 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2017-10-06 | 재개 | Goldman | Neutral |
| 2017-09-13 | 재확인 | Chardan Capital Markets | Buy |
| 2017-08-10 | 재확인 | Chardan Capital Markets | Buy |
| 2017-01-24 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2016-05-18 | 개시 | BofA/Merrill | Buy |
| 2016-04-14 | 개시 | Robert W. Baird | Neutral |
| 2016-04-12 | 재확인 | Chardan Capital Markets | Buy |
| 2015-09-16 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2015-06-16 | 재확인 | Chardan Capital Markets | Buy |
모두보기
아미쿠스 테라 주식(FOLD)의 최신 뉴스
Squarepoint Ops LLC Sells 621,037 Shares of Amicus Therapeutics, Inc. $FOLD - MarketBeat
Hudson Bay Capital Management LP Sells 257,720 Shares of Amicus Therapeutics, Inc. $FOLD - MarketBeat
Amicus Therapeutics Stock Dips Amid Market Volatility - StocksToTrade
Amicus Therapeutics (FOLD) Stock News, Forecasts and Analyst Outlook on Dec. 14, 2025: What’s Driving the Rally? - ts2.tech
Amicus Therapeutics Surges Amid Price Volatility and Market Dynamics - timothysykes.com
Why Amicus Therapeutics (FOLD) Is Up 6.6% After Bullish Analyst Upgrades On Earnings Outlook - Yahoo Finance
Amicus Therapeutics (NASDAQ:FOLD) Hits New 12-Month HighStill a Buy? - MarketBeat
Amicus Therapeutics Capitalizes on Strategic Expansion and Surges in Stock Price - StocksToTrade
Amicus Therapeutics’ Stock Benefits from Financial Resilience Despite Marginal Decline - timothysykes.com
Analyst Upgrade: Is Amicus Therapeutics Inc stock a smart buy before Fed meetingJuly 2025 Fed Impact & Low Risk Entry Point Guides - moha.gov.vn
Amicus Therapeutics (FOLD) Soars to 52-Week High on ‘Strong Buy’ Reco - MSN
683 Capital Management LLC Acquires 685,000 Shares of Amicus Therapeutics, Inc. $FOLD - MarketBeat
Amicus Therapeutics stock hits 52-week high at 10.61 USD By Investing.com - Investing.com Nigeria
Amicus Therapeutics stock hits 52-week high at 10.61 USD - Investing.com
Wall Street Analysts See a 60.61% Upside in Amicus Therapeutics (FOLD): Can the Stock Really Move This High? - Finviz
Redmile Group LLC Sells 8,344,671 Shares of Amicus Therapeutics, Inc. $FOLD - MarketBeat
Osterweis Capital Management Inc. Sells 573,805 Shares of Amicus Therapeutics, Inc. $FOLD - MarketBeat
Jump Financial LLC Raises Stake in Amicus Therapeutics, Inc. $FOLD - MarketBeat
How Amicus Therapeutics Inc. (FOLD) Affects Rotational Strategy Timing - news.stocktradersdaily.com
3,235,538 Shares in Amicus Therapeutics, Inc. $FOLD Bought by Norges Bank - MarketBeat
Amicus Therapeutics, Inc. $FOLD Shares Sold by JPMorgan Chase & Co. - MarketBeat
Can Galafold continue to drive Amicus' top line in 2026? - MSN
Amicus Therapeutics, Inc. $FOLD Shares Sold by Prudential Financial Inc. - MarketBeat
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Surging Earnings Estimates Signal Upside for Amicus Therapeutics (FOLD) Stock - Finviz
Can Galafold Continue to Drive Amicus' Top Line in 2026? - Yahoo Finance
Schroder Investment Management Group Purchases 649,177 Shares of Amicus Therapeutics, Inc. $FOLD - MarketBeat
What is the fair value estimate for Amicus Therapeutics Inc. (AM6) stock in 2025Quarterly Portfolio Summary & Free Real-Time Volume Trigger Notifications - Newser
Amicus Therapeutics (NASDAQ:FOLD) CEO Sells 14,587 Shares - MarketBeat
Is Amicus Therapeutics Inc. (AM6) stock nearing a technical breakout2025 Analyst Calls & Consistent Profit Trade Alerts - Newser
BMY Gains on News of Continuation of Alzheimer's Disease Study - Finviz
Amicus Therapeutics (FOLD) Up 6.4% Since Last Earnings Report: Can It Continue? - Yahoo Finance
How Amicus Therapeutics Inc. (AM6) stock performs in volatility spikes2025 Trading Recap & Reliable Breakout Stock Forecasts - Newser
Pompe Disease Treatment Market is expected to reach US$ 4.06 - openPR.com
Amicus Therapeutics CEO Sells Shares - TradingView
What analysts say about Amicus Therapeutics Inc stockStock Valuation Metrics & We Spotted the Next Tesla – See Inside - earlytimes.in
Will Amicus Therapeutics Inc. (AM6) stock benefit from mergersLong Setup & Safe Capital Growth Stock Tips - Newser
Capital Fund Management S.A. Has $4.37 Million Stake in Amicus Therapeutics, Inc. $FOLD - MarketBeat
Will Amicus Therapeutics Inc. stock benefit from commodity pricesJuly 2025 Highlights & Reliable Entry Point Trade Alerts - Newser
Why Amicus Therapeutics Inc. (AM6) stock could break out in 2025Recession Risk & Daily Profit Maximizing Tips - Newser
Amicus Therapeutics, Inc. $FOLD Stock Position Raised by Virtus Investment Advisers LLC - MarketBeat
Creative Planning Purchases 180,652 Shares of Amicus Therapeutics, Inc. $FOLD - MarketBeat
Advantage Alpha Capital Partners LP Makes New Investment in Amicus Therapeutics, Inc. $FOLD - MarketBeat
Assessing Amicus Therapeutics (FOLD) Valuation as Shares Gain 11% Over Past Month - Yahoo Finance
How Strong Galafold and Pombiliti Sales Helped Amicus Therapeutics (FOLD) Surpass Expectations and Shift Its Outlook - Yahoo Finance
Intech Investment Management LLC Sells 47,907 Shares of Amicus Therapeutics, Inc. $FOLD - MarketBeat
Amicus Therapeutics, Inc. $FOLD Stock Holdings Increased by Jefferies Financial Group Inc. - MarketBeat
Geode Capital Management LLC Sells 57,278 Shares of Amicus Therapeutics, Inc. $FOLD - MarketBeat
Envestnet Asset Management Inc. Has $368,000 Stock Holdings in Amicus Therapeutics, Inc. $FOLD - MarketBeat
David Michael Clark Sells 25,643 Shares of Amicus Therapeutics (NASDAQ:FOLD) Stock - MarketBeat
Insider Selling: Amicus Therapeutics (NASDAQ:FOLD) CEO Sells 14,587 Shares of Stock - MarketBeat
아미쿠스 테라 (FOLD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.08%
0.91%
자본화:
|
볼륨(24시간):